These findings suggest that FABP4 may serve as a valuable prognostic and diagnostic marker for obesity and diabetes, particularly among female patients, individuals over 50 years old, and specific ethnic groups. This evidence concerns the gene FABP4 and obesity due to melanocortin 4 receptor deficiency.